Recent progress in Nanomaterial based biosensors for the detection of cancer biomarkers in human fluids DOI
Razu Shahazi, Amirul Islam Saddam, Md Rakibul Islam

и другие.

Deleted Journal, Год журнала: 2024, Номер 2(2), С. 1254 - 1254

Опубликована: Июль 18, 2024

Cancer is a global health challenge, and early detection crucial for effective treatment to improve patient outcomes. In recent years, nanomaterial-based biosensors have emerged as powerful tools the of cancer biomarkers in human fluids. This article highlights progress biosensor technology biomarkers, focusing on advancements sensitivity, selectivity, multiplexed detection, liquid biopsies, point-of-care testing, wearable biosensors, integration with artificial intelligence (AI). Recent significantly improved sensitivity selectivity allowing low concentrations complex biological samples. Novel sensing technologies, such sensors aptamer-based sensors, played role enhancing performance. Multiplexed ability simultaneously detect multiple providing comprehensive diagnostic information. capability particularly valuable accurate diagnosis prognosis. Liquid which involve circulating tumor cells, cell-free DNA, or exosomes present body fluids, gained considerable attention. Biosensors pivotal development biopsy offering non-invasive real-time monitoring progression, response, emergence drug resistance. Integration AI algorithms has shown great potential. can analyze interpret data, identifying patterns, correlations, biomarker signatures that may be difficult traditional methods.

Язык: Английский

Recent progress in Nanomaterial based biosensors for the detection of cancer biomarkers in human fluids DOI
Razu Shahazi, Amirul Islam Saddam, Md Rakibul Islam

и другие.

Deleted Journal, Год журнала: 2024, Номер 2(2), С. 1254 - 1254

Опубликована: Июль 18, 2024

Cancer is a global health challenge, and early detection crucial for effective treatment to improve patient outcomes. In recent years, nanomaterial-based biosensors have emerged as powerful tools the of cancer biomarkers in human fluids. This article highlights progress biosensor technology biomarkers, focusing on advancements sensitivity, selectivity, multiplexed detection, liquid biopsies, point-of-care testing, wearable biosensors, integration with artificial intelligence (AI). Recent significantly improved sensitivity selectivity allowing low concentrations complex biological samples. Novel sensing technologies, such sensors aptamer-based sensors, played role enhancing performance. Multiplexed ability simultaneously detect multiple providing comprehensive diagnostic information. capability particularly valuable accurate diagnosis prognosis. Liquid which involve circulating tumor cells, cell-free DNA, or exosomes present body fluids, gained considerable attention. Biosensors pivotal development biopsy offering non-invasive real-time monitoring progression, response, emergence drug resistance. Integration AI algorithms has shown great potential. can analyze interpret data, identifying patterns, correlations, biomarker signatures that may be difficult traditional methods.

Язык: Английский

Процитировано

3